ArticleThe AAPS journal2019

Fc-Fusion Drugs Have FcγR/C1q Binding and Signaling Properties That May Affect Their Immunogenicity.

H A Daniel Lagassé et al.PubMed ↗Publisher ↗

No numbers read from the abstract.